Lymphocytes protect cortical neurons against excitotoxicity mediated by kainic acid, an in vitro model for neurodegeneration

Kathmandu University Medical Journal

Volumn 11, Issue 42, 2013, Pages 132-138

  Shrestha, Rajeev ^a,c   Millington, O ^a   Brewer, J ^a   Bushell, T ^b  

^a UNIVERSITY OF STRATHCLYDE   (United Kingdom)

^b UNIVERSITY OF GLASGOW   (United Kingdom)

^c KATHMANDU UNIVERSITY SCHOOL OF MEDICAL SCIENCES   (Nepal)

Author keywords

Astrocytes; Lymphocytes; Neurodegeneraton; Neuroprotecton; T cells

Indexed keywords

KAINIC ACID; PROPIDIUM IODIDE;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; ASTROCYTE; B LYMPHOCYTE; BRAIN CELL; CELL DEATH; CENTRAL NERVOUS SYSTEM DISEASE; CONTROLLED STUDY; DISEASE MODEL; EXCITOTOXICITY; IN VITRO STUDY; MOUSE; NERVE DEGENERATION; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; SLICE CULTURE; T CELL DEPLETION; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; ANIMAL EXPERIMENT; ANIMAL MODEL; BRAIN SLICE; CELL ASSAY; IMMUNE RESPONSE; LYMPHOCYTE FUNCTION; MOLECULAR DYNAMICS;

ANIMALS; B-LYMPHOCYTES; CELL DEATH; DISEASE MODELS, ANIMAL; INFLAMMATION; KAINIC ACID; LYMPHOCYTES; MICE; NEURODEGENERATIVE DISEASES; NEURONS; NEUROPROTECTIVE AGENTS; T-LYMPHOCYTES;

EID: 84884485663     PISSN: 18122027     EISSN: 18122078     Source Type: Journal    
DOI: 10.3126/kumj.v11i2.12488     Document Type: Article

References (39)

1. Tollervey JR, Wang Z, Hortobãgyi T, Witen JT, Zarnack K, Kayikci M, et al. Analysis of alternatve splicing associated with aging and neurodegeneraton in the human brain. Genome Research 2011.
2. Amor S, Puentes F, Baker D, and Van Der Valk P,. Infammaton in neurodegeneratve diseases. Immunology 2010;129(2):154-169.
3. Bramlet HM and Dietrich WD. Pathophysiology of cerebral ischemia and brain trauma: similarites and diferences. J Cereb Blood Flow Metab 2004;24(2):133-150.
4. Elbaz A, Dufouil C, and Alpérovitch A. Interacton between genes and environment in neurodegeneratve diseases. Comptes Rendus Biologies 2007;330(4):318-328.
5. Lee J-K, Tran T, and Tansey M. Neuroinfammaton in Parkinsons Disease. Journal of Neuroimmune Pharmacology 2009;4(4):419-429.
6. Gabuzda D and Yankner BA. Physiology: Infammaton links ageing to the brain. Nature 2013;497(7448):197-198.
7. Wang Q, Yu S, Simonyi A, Sun GY, and Sun AY. Kainic acid-mediated excitotoxicity as a model for neurodegeneraton. Mol Neurobiol 2005; 31(1-3):3-16.
8. Greenwood SM and Bushell TJ. Astrocytc actvaton and an inhibiton of MAP kinases are required for proteinase-actvated receptor-2-mediated protecton from neurotoxicity. J Neurochem, 2010;113(6): 1471-1480.
9. Gan J, Greenwood SM, Cobb SR, and Bushell TJ. Indirect modulaton of neuronal excitability and synaptc transmission in the hippocampus by actvaton of proteinase-actvated receptor-2. Britsh Journal of Pharmacology 2011;163(5):984-994.
10. Larochelle C, Alvarez JI, and Prat A. How do immune cells overcome the blood-brain barrier in multple sclerosis? FEBS Leters 2011; 585(23):3770-3780.
11. Grammas P. Neurovascular dysfuncton, infammaton and endothelial actvaton: implicatons for the pathogenesis of Alzheimer's disease. Journal of Neuroinfammaton 2011;8:26.
12. Qian L, Flood PM, and Hong JS. Neuroinfammaton is a key player in Parkinson's disease and a prime target for therapy. J Neural Transm 2010;117(8):971-979.
13. Beck KD, Nguyen HX, Galvan MD, Salazar DL, Woodruf TM, and Anderson AJ. Quanttatve analysis of cellular infammaton afer traumatc spinal cord injury: evidence for a multphasic infammatory response in the acute to chronic environment. Brain 2010;133(Pt 2): 433-447.
14. Serpe CJ, Kohm AP, Huppenbauer CB, Sanders VM, and Jones KJ. Exacerbaton of facial motoneuron loss afer facial nerve transecton in severe combined immunodefcient (scid) mice. J Neurosci 1999;19(11):RC7.
15. Xin J, Wainwright DA, Mesnard NA, Serpe CJ, Sanders VM, and Jones KJ. IL-10 within the CNS is necessary for CD4+ T cells to mediate neuroprotecton. Brain, Behavior, and Immunity 2011;25(5):820-829.
16. Liesz A, Suri-Payer E, Veltkamp C, Doerr H, Sommer C, Rivest S, et al. Regulatory T cells are key cerebroprotectve immunomodulators in acute experimental stroke. Nat Med 2009;15(2):192-199.
17. Wolf SA, Fisher J, Bechmann I, Steiner B, Kwidzinski E, and Nitsch R. Neuroprotecton by T-cells depends on their subtype and actvaton state. J Neuroimmunol 2002;133(1-2):72-80.
18. Zheng X-Y, Zhang H-L, Luo Q, and Zhu J. Kainic Acid-Induced Neurodegeneratve Model: Potentals and Limitatons. Journal of Biomedicine and Biotechnology 2011.
19. Rook GA, Lowry CA, and Raison CL. Lymphocytes in neuroprotecton, cogniton and emoton: is intolerance really the answer? Brain Behav Immun 2011;25(4):591-601.
20. Ren X, Akiyoshi K, Dziennis S, Vandenbark AA, Herson PS, Hurn PD, et al. Regulatory B Cells Limit CNS Infammaton and Neurologic Defcits in Murine Experimental Stroke. The Journal of Neuroscience 2011. 31(23):8556-8563.
21. Liu Y, Teige I, Birnir B, and Issazadeh-Navikas S. Neuron-mediated generaton of regulatory T cells from encephalitogenic T cells suppresses EAE. Nat Med 2006;12(5):518-525.
22. Hendrix S and Nitsch R. The role of T helper cells in neuroprotecton and regeneraton. J Neuroimmunol 2007;184(1-2):100-112.
23. Yong VW and Marks S. The interplay between the immune and central nervous systems in neuronal injury. Neurology 2010;74 Suppl 1:S9-S16.
24. Roy A, Liu X, and Pahan K. Myelin basic protein-primed T cells induce neurotrophins in glial cells via alphavbeta3 [corrected] integrin. J Biol Chem 2007;282(44):32222-32232.
25. Matsushita T, Horikawa M, Iwata Y, and Tedder TF. Regulatory B cells (B10 cells) and regulatory T cells have independent roles in controlling experimental autoimmune encephalomyelits initaton and late-phase immunopathogenesis. J Immunol 2010;185(4):2240-2252.
26. Kala M, Rhodes SN, Piao WH, Shi FD, Campagnolo DI, and Vollmer TL. B cells from glatramer acetate-treated mice suppress experimental autoimmune encephalomyelits. Exp Neurol 2010;221(1):136-145.
27. Zhou Z, Peng X, Insolera R, Fink DJ, and Mata M. IL-10 promotes neuronal survival following spinal cord injury. Experimental Neurology 2009;220(1):183-190.
28. Ruocco A, Nicole O, Docagne F, Ali C, Chazalviel L, Komesli S, et al. A Transforming Growth Factor-[beta] Antagonist Unmasks the Neuroprotectve Role of This Endogenous Cytokine in Excitotoxic and Ischemic Brain Injury. J Cereb Blood Flow Metab 1999;19(12):1345-1353.
29. Caraci F, Bataglia G, Bruno V, Bosco P, Carbonaro V, Giufrida ML, et al. TGF-beta1 pathway as a new target for neuroprotecton in Alzheimer's disease. CNS neuroscience & therapeutcs 2011;17(4): 237-249.
30. Hammarberg H, Lidman O, Lundberg C, Eltayeb SY, Gielen AW, Muhallab S, et al. Neuroprotecton by Encephalomyelits: Rescue of Mechanically Injured Neurons and Neurotrophin Producton by CNS-Infltratng T and Natural Killer Cells. The Journal of Neuroscience 2000;20(14):5283-5291.
31. Linker R, Gold R, and Luhder F. Functon of neurotrophic factors beyond the nervous system: infammaton and autoimmune demyelinaton. Critcal reviews in immunology 2009;29(1):43-68.
32. Belanger M and Magistret PJ. The role of astroglia in neuroprotecton. Dialogues Clin Neurosci 2009;11(3):281-295.
33. Perea G, Navarrete M, and Araque A. Tripartte synapses: astrocytes process and control synaptc informaton. Trends in neurosciences 2009;32(8):421-431.
34. Barker AJ and Ullian EM. Astrocytes and synaptc plastcity. The Neuroscientst: a review journal bringing neurobiology. Neurology and psychiatry 2010;6(1):40-50.
35. Halliday GM and Stevens CH, Glia: initators and progressors of pathology in Parkinson's disease. Movement disorders: ofcial journal of the Movement Disorder Society 2011;26(1):6-17.
36. Tomac A, Lindqvist E, Lin LF, Ogren SO, Young D, Hofer BJ, et al. Protecton and repair of the nigrostriatal dopaminergic system by GDNF in vivo. Nature 1995;373(6512):335-339.
37. Spina MB, Hyman C, Squinto S, and Lindsay RM. Brain-derived neurotrophic factor protects dopaminergic cells from 6-hydroxydopamine toxicity. Annals of the New York Academy of Sciences 1992;648:348-350.
38. Pertusa M, Garcia-Matas S, Mammeri H, Adell A, Rodrigo T, Mallet J, et al. Expression of GDNF transgene in astrocytes improves cognitve defcits in aged rats. Neurobiology of Aging 2008;29(9):1366-1379.
39. Mickiewicz AL and Kordower JH. GDNF family ligands: a potental future for Parkinson's disease therapy. CNS & neurological disorders drug targets 2011;10(6):703-711.